Ellen Cahir-McFarland

Company: Annexon Biosciences
Job title: Senior Vice President, Research
Seminars:
Stop the Start: The Effect of Anti-C1q Inhibitors on Neurodegeneration 2:00 pm
C1q tags membranes for elimination via classical complement activation by microglia or macrophages Anti-C1q inhibitors provide synaptic and neuronal protection in multiple mouse models Annexon has developed fit-for-purpose C1q inhibitors for Ophthalmology and Neurodegeneration that have demonstrated proof of biologyRead more
day: Track A - Day 1 PM